SCHEMBL18597850

SCHEMBL18597850

CC(=O)OCOC(=O)[C@H](O)C[C@@H](Cc1ccc(-c2cc(Cl)ccc2/C=C\I)cc1)NC(=O)C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 19/20 0.43
▸ ACE P12821 9/20 0.43
▸ MMEL1 Q495T6 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14900580 0.83 MME (0.62) MMEACEMMEL1
SCHEMBL14900581 0.75 MME (0.59) MMEACEMMEL1
SCHEMBL23055193 0.75 MME (0.59) MMEACEMMEL1
SCHEMBL17011366 0.75 MME (0.59) MMEACEMMEL1
SCHEMBL19190446 0.75 MME (0.59) MMEACEMMEL1
SCHEMBL14890894 0.72 MME (0.78) MMEACEMMEL1
SCHEMBL18597854 0.71 MME (0.65) MMEACEMMEL1
SCHEMBL14932476 0.71 MME (0.65) MMEACEMMEL1
SCHEMBL14890856 0.71 MME (0.77) MMEACEMMEL1
SCHEMBL16930520 0.70 MME (0.55) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773335-B1 OXALIC ACID AMIDES AS NEPRILYSIN INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND PREPARATION THEREOF THERAVANCE BIOPHARMA R&D IP LLC (US) 2017-03-08 — — EP disclosed
Send feedback